Lilly-Backed Ampersand Raises $65M for Preclinical Immunology and Computational Drug Discovery
Ampersand Biomedicines has raised $65 million in a Series B funding round, with participation from Eli Lilly and Company and …
News
Microsoft and Inait to Develop Brain-Inspired AI for Finance and Robotics
Microsoft and Swiss startup Inait have announced a partnership to develop AI models inspired by mammalian brain function. Microsoft plans …
Proscia Raises $50M to Expand AI Pathology Platform and Precision Medicine Tools
Proscia, a developer of AI-based pathology software, has raised $50 million in funding, bringing its total capital raised to $130 …
Synchron and NVIDIA Collaborate on Real-Time Neural Processing for BCIs
Synchron, a developer of implantable brain-computer interface (BCI) technology, has announced a collaboration with NVIDIA to enhance its next-generation BCI …
Sofinnova Raises €165M to Back European Biotech Startups
Sofinnova Partners, a European life sciences venture capital firm, has closed its Biovelocita II fund at €165 million, surpassing its …
Researchers Develop AI Tool that Maps Cellular "Social Networks" to Guide Cancer Treatment
Researchers have developed a new artificial intelligence (AI) tool that can analyze how cells communicate within tissues, potentially guiding more …
UK Company Secures £600,000 for 3D Lung Model to Replace Animal Testing
ImmuONE, a UK-based biotech company developing a 3D human lung model for drug and chemical testing, has secured £600,000 in …
Elsevier Launches ScienceDirect AI to Provide Summarized Research Insights
Elsevier launched ScienceDirect AI, a new generative AI tool designed to help researchers quickly access and summarize key findings from …
Tempus Acquires AI-Powered Clinical Trial Matching Platform
Tempus AI has announced the acquisition of a clinical trial matching platform Deep 6 AI, which applies artificial intelligence (AI) …
Insilico Medicine Raises $110M to Advance AI Drug Design, Unveils its Humanoid Lab Robot
Insilico Medicine has raised $110 million in Series E funding to support clinical trials and further develop its AI-driven drug …
Lila Sciences Raises $200M to Automate Scientific Discovery with AI and Robotics
Flagship Pioneering has announced the launch of Lila Sciences, a company developing an AI-based platform designed to automate scientific experimentation …
AI-Powered Immune Mapping Company Appoints Ex-Pfizer R&D Chief to Its Board
Immunai has appointed Mikael Dolsten, M.D., Ph.D., former Chief Scientific Officer and President of Research & Development at Pfizer, to …